AI and Drug Development: IP and data protection challenges

Artificial intelligence (AI) is not new to the life sciences industry but its use in drug development is rapidly growing, as life sciences companies increasingly recognize the benefits of...

London: Life Sciences and Health Care Horizons 2019

We are excited to announce our speakers at this year's Hogan Lovells Life Sciences Summit.

Loading data